Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Change in Accured Expenses (2016 - 2026)

Pharma-Bio Serv's Change in Accured Expenses history spans 17 years, with the latest figure at -$148056.0 for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 30.54% year-over-year to -$148056.0; the TTM value through Jan 2026 reached -$787921.0, up 20.36%, while the annual FY2025 figure was -$853006.0, 29.35% up from the prior year.
  • Change in Accured Expenses reached -$148056.0 in Q1 2026 per PBSV's latest filing, down from $79597.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $170854.0 in Q3 2023 to a low of -$597831.0 in Q2 2025.
  • Average Change in Accured Expenses over 5 years is -$192035.3, with a median of -$174474.5 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 305.27% in 2023, then tumbled 1618.45% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$83385.0 in 2022, then crashed by 285.47% to -$321427.0 in 2023, then soared by 83.03% to -$54545.0 in 2024, then surged by 245.93% to $79597.0 in 2025, then tumbled by 286.01% to -$148056.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Change in Accured Expenses are -$148056.0 (Q1 2026), $79597.0 (Q4 2025), and -$121631.0 (Q3 2025).